A Study to Learn About How Safe BAY3018250 is and What Happens to it in Healthy Japanese Men and Adult Participants Aged 18 to 55 Years

NCT06562985 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Venous and Arterial Thrombotic and Thromboembolic Events
Healthy Volunteers

Interventions

DRUG: BAY3018250 Dose 1
DRUG: Placebo
DRUG: Placebo
DRUG: BAY3018250 Dose 2 infusion
DRUG: BAY3018250 Dose 2 injection

Sponsor

Bayer